Myriad Genetics Expands Minimal Residual Disease Testing for Three Cancer Types
The whole-genome sequencing assay is now available for breast, colorectal, and renal cancers following new clinical study results.
Read More
Search Results for: liver disease
Labcorp Launches RNA-Based At-Home Colorectal Cancer Test Nationwide
The test detect signs of colorectal cancer and precancerous growths using a home collection kit.
Read More
Study to Evaluate One-Hour Testing for Drug-Resistant Infections
The Fleming Initiative and Cepheid have launched a 30-month study in England to compare rapid molecular and traditional culture screening for drug-resistant carbapenemase-producing Enterobacterales in hospital settings.
Read More
A Year of Firsts for Alzheimer’s Blood Testing
With the first FDA-cleared test and clinical guidelines debuting since May 2025, labs are evaluating how blood-based biomarkers fit into diagnostic protocols.
Read More
Bruker Expands Microbiology and Infection Diagnostics Portfolio
New updates include expanded capabilities for microbial identification and advancements in sepsis diagnostics and sequencing workflows.
Read More